Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
25.57
+0.84 (3.40%)
At close: Jun 26, 2026, 4:00 PM EDT
25.34
-0.23 (-0.90%)
After-hours: Jun 26, 2026, 7:07 PM EDT
Denali Therapeutics Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for Denali Therapeutics stock have an average target of 34.55, with a low estimate of 23 and a high estimate of 42. The average target predicts an increase of 35.12% from the current stock price of 25.57.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Denali Therapeutics stock from 19 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 17 | 17 | 17 | 17 | 17 | 17 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 19 | 19 | 19 | 19 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Buy Maintains $25 | Buy | Maintains | $25 | -2.23% | Jun 16, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $40 → $35 | Buy | Maintains | $40 → $35 | +36.88% | May 26, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 22, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 22, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $40 | Buy | Maintains | $40 | +56.43% | May 22, 2026 |
Financial Forecast
Revenue This Year
41.00M
Revenue Next Year
113.17M
from 41.00M
Increased by 176.03%
EPS This Year
-2.32
from -2.97
EPS Next Year
-2.48
from -2.32
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 237.6M | 218.9M | |
| Avg | 41.0M | 113.2M | |
| Low | 4.3M | 35.0M |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | 433.9% | 762.5% |
| Avg | 176.0% | 269.9% |
| Low | -14.6% | -36.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.21 | -1.80 | |
| Avg | -2.32 | -2.48 | |
| Low | -2.97 | -2.89 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.